Full Text
COST-MINIMIZATION ANALYSIS OF BIOLOGICAL DRUGS IN THE TREATMENT OF RHEUMATOID ARTHRITIS UNDER THE BRAZILIAN PRIVATE HEALTH SYSTEM PERSPECTIVE

Abstract

Authors

L. Scaccabarozzi E. Asano A.C. Monteiro

Back to Volume 19, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×